Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synthetic MR ABSTU:9480 +3.10%63 Market Cap is €5.02 Mil as of Jul. 15, 2026. GuruFocus rates STU:9480 with a GF Score™ of 63/100 and a GF Value™ of €0.26 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 698 Healthcare Providers & Services companies, Synthetic MR AB ranks worse than 89.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Synthetic MR AB's share price for the quarter that ended in Mar. 2026 was €0.0486. Synthetic MR AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 89.33 Mil. Therefore, Synthetic MR AB's market cap for the quarter that ended in Mar. 2026 was €4.34 Mil.
Synthetic MR AB's quarterly market cap
declined
from Sep. 2025 (€12.44 Mil) to Dec. 2025 (€7.60 Mil) and
declined
from Dec. 2025 (€7.60 Mil) to Mar. 2026 (€4.34 Mil).
Synthetic MR AB's annual market cap
increased
from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€16.69 Mil) but then
declined
from Dec. 2024 (€16.69 Mil) to Dec. 2025 (€7.60 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Synthetic MR AB's Enterprise Value for Today is €2.05 Mil.
Synthetic MR AB (STU:9480) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Synthetic MR AB Market Cap Related Terms
Synthetic MR AB Market Cap Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:9480 vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, Synthetic MR AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Synthetic MR AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB (STU:9480) has a Market Cap of €5.02 Mil as of Jul. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Synthetic MR AB and its competitors. According to the industry distribution chart, Synthetic MR AB ranks #623 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 89.3%.
Is Synthetic MR AB's Market Cap too high?
Synthetic MR AB's current Market Cap is €5.02 Mil. Based on the distribution chart, Synthetic MR AB ranks #623 out of 698 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #623 out of 698 companies for Market Cap. This places Synthetic MR AB in the lower half of its industry. The industry median Market Cap is 101.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 101.13, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 101.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current Market Cap is €5.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (STU:9480) is currently considered Possible Value Trap. The stock's GF Value™ is €0.26, compared to a current price of €0.03 — trading 89.8% below its estimated fair value. The current Market Cap is €5.02 Mil. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Synthetic MR AB (STU:9480), the current Market Cap is €5.02 Mil as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (STU:9480) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of €0.03 is trading 89.8% below its estimated GF Value™ of €0.26.
GuruFocus considers Synthetic MR AB to be Possible Value Trap.
Key valuation signals for STU:9480:
Market Cap: €5.02 Mil
GF Value™: €0.26 vs. price of €0.03 (89.8% below fair value)
No single metric tells the full story. See the STU:9480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score
Get the complete analysis for STU:9480
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:9480 has been successfully added to your 
